Sodium-glucose transport-2 (SGLT-2) inhibitors Clinical Trials

1 actively recruiting trial

Also known as: Dapagliflozin 10mg in addition to standard clinical care

Top Sponsors

University of Aberdeen1

Indications

Breast Cancer1
Cancer1

Other1 trial

Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.